huge potential for car-t therapy in myeloma
Published 5 years ago • 63 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
3:03
the future of car-t therapy for multiple myeloma
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
2:01
car-t updates in myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
2:40
recent advances in car-t therapy for mds
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
3:27
car-t cells in myeloma
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
2:23
improving car t-cell therapy for myeloma
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:37
car-t cells for myeloma: experience from china
-
3:10
universal car-t therapy for t-all